Ilan Hadar - Net Worth and Insider Trading

Ilan Hadar Net Worth

The estimated net worth of Ilan Hadar is at least $266,944 dollars as of 2024-11-13. Ilan Hadar is the CFO & Country Manager of Foamix Pharmaceuticals Ltd and owns about 89,279 shares of Foamix Pharmaceuticals Ltd (FOMX) stock worth over $266,944. Details can be seen in Ilan Hadar's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ilan Hadar has not made any transactions after 2019-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ilan Hadar

To

Ilan Hadar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ilan Hadar owns 2 companies in total, including VYNE Therapeutics Inc (VYNE) , and Foamix Pharmaceuticals Ltd (FOMX) .

Click here to see the complete history of Ilan Hadar’s form 4 insider trades.

Insider Ownership Summary of Ilan Hadar

Ticker Comapny Transaction Date Type of Owner
VYNE VYNE Therapeutics Inc 2020-03-09 CFO and Country Manager
FOMX Foamix Pharmaceuticals Ltd 2020-03-09 CFO & Country Manager

Ilan Hadar Latest Holdings Summary

Ilan Hadar currently owns a total of 1 stock. Ilan Hadar owns 89,279 shares of Foamix Pharmaceuticals Ltd (FOMX) as of September 10, 2019, with a value of $266,944.

Latest Holdings of Ilan Hadar

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FOMX Foamix Pharmaceuticals Ltd 2019-09-10 89,279 2.99 266,944

Holding Weightings of Ilan Hadar


Ilan Hadar Form 4 Trading Tracker

According to the SEC Form 4 filings, Ilan Hadar has made a total of 0 transactions in Foamix Pharmaceuticals Ltd (FOMX) over the past 5 years. The most-recent trade in Foamix Pharmaceuticals Ltd is the sale of 43,812 shares on September 10, 2019, which brought Ilan Hadar around $153,342.

Insider Trading History of Ilan Hadar

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ilan Hadar Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ilan Hadar Ownership Network

Ownership Network List of Ilan Hadar

No Data

Ownership Network Relation of Ilan Hadar

Insider Network Chart

Ilan Hadar Owned Company Details

What does VYNE Therapeutics Inc do?

Who are the key executives at VYNE Therapeutics Inc?

Ilan Hadar is the CFO and Country Manager of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .

VYNE Therapeutics Inc (VYNE) Insider Trades Summary

Over the past 18 months, Ilan Hadar made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 13,000 shares made by Patrick G Lepore ,

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

VYNE Therapeutics Inc Insider Transactions

No Available Data

Ilan Hadar Mailing Address

Above is the net worth, insider trading, and ownership report for Ilan Hadar. You might contact Ilan Hadar via mailing address: C/o Foamix Pharmaceuticals Ltd., 2 Holzman Street, Weizmann Science Park, Rehovot L3 76704.